Rab29 activation of the Parkinson's disease-associated LRRK2 kinase (vol 37, pg 1, 2018)

被引：8
|
作者：
Purlyte, Elena
Dhekne, Herschel S.
Sarhan, Adil R.
Gomez, Rachel
Lis, Pawel
Wightman, Melanie
Martinez, Terina N.
Tonelli, Francesca
Pfeffer, Suzanne R.
Alessi, Dario R.
机构：
来源：
EMBO JOURNAL | 2019年 / 38卷 / 02期
基金：
英国医学研究理事会;
关键词：
D O I：
10.15252/embj.2018101237
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
[graphic not available: see fulltext]
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Distinctive roles of Rac1 and Rab29 in LRRK2 mediated membrane trafficking and neurite outgrowth
    Min Feng
    Xin Hu
    Na Li
    Fan Hu
    Fei Chang
    Hongfei Xu
    Yongjian Liu
    TheJournalofBiomedicalResearch, 2018, 32 (02) : 145 - 156
  • [22] Development of LRRK2 Kinase Inhibitors for Parkinson's Disease
    Galatsis, Paul
    Henderson, Jaclyn
    Kormos, Bethany L.
    Hirst, Warren D.
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 49, 2014, 49 : 43 - 58
  • [23] Identification of chemicals to inhibit the kinase activity of leucine-rich repeat kinase 2 (LRRK2), a Parkinson's disease-associated protein
    Yun, HyeJin
    Heo, Hye Young
    Kim, Hyun Ha
    DooKim, Nam
    Seol, Wongi
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (10) : 2953 - 2957
  • [24] A designed ankyrin-repeat protein that targets Parkinson's disease-associated LRRK2
    Dederer, Verena
    Murillo, Marta Sanz
    Karasmanis, Eva P.
    Hatch, Kathryn S.
    Chatterjee, Deep
    Preuss, Franziska
    Azeez, Kamal R. Abdul
    Nguyen, Landon Vu
    Galicia, Christian
    Dreier, Birgit
    Plueckthun, Andreas
    Versees, Wim
    Mathea, Sebastian
    Leschziner, Andres E.
    Reck-Peterson, Samara L.
    Knapp, Stefan
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2024, 300 (07)
  • [25] The Parkinson's disease-associated protein, leucine-rich repeat kinase 2 (LRRK2), is an authentic GTPase that stimulates kinase activity
    Guo, Luxuan
    Gandhi, Payal N.
    Wang, Wen
    Petersen, Robert B.
    Wilson-Delfosse, Amy L.
    Chen, Shu G.
    EXPERIMENTAL CELL RESEARCH, 2007, 313 (16) : 3658 - 3670
  • [26] An Update on the Interplay between LRRK2, Rab GTPases and Parkinson's Disease
    Komori, Tadayuki
    Kuwahara, Tomoki
    BIOMOLECULES, 2023, 13 (11)
  • [27] GTPase Activity and Neuronal Toxicity of Parkinson's Disease-Associated LRRK2 Is Regulated by ArfGAP1
    Stafa, Klodjan
    Trancikova, Alzbeta
    Webber, Philip J.
    Glauser, Liliane
    West, Andrew B.
    Moore, Darren J.
    PLOS GENETICS, 2012, 8 (02):
  • [28] Search for potential targets of LRRK2 kinase associated with Parkinson disease
    Ziganshin, R.
    Lebedeva, O.
    Azarkin, I.
    Lagarkova, M.
    FEBS OPEN BIO, 2018, 8 : 154 - 154
  • [29] LRRK2 Ashkenazi Jewish Consortium. Progression in the LRRK2-associated Parkinson disease population (vol 75, pg 312, 2018)
    Saunders-Pullman, R.
    Mirelman, A.
    Alcalay, R. N.
    JAMA NEUROLOGY, 2018, 75 (06) : 763 - 763
  • [30] LRRK2 directly phosphorylates Akt1 as a possible physiological substrate: Impairment of the kinase activity by Parkinson's disease-associated mutations
    Ohta, Etsuro
    Kawakami, Fumitaka
    Kubo, Makoto
    Obata, Fumiya
    FEBS LETTERS, 2011, 585 (14) : 2165 - 2170
12345